Strong dependence of the critical irradiation dose on PTEN, Wip1, and PI3K expression may suggest that pretreatment of cancer cells (with intact p53) with drugs that act temporally to elevate the expression of PTEN or to repress the expression of Wip1 or PI3K can enhance the effectiveness of radiotherapy. Here, TP53 is linked to cancer.